+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy in a pediatric patient with stage III Hodgkin lymphoma



Proton therapy in a pediatric patient with stage III Hodgkin lymphoma



Acta Oncologica 52(3): 592-594




(PDF emailed within 0-6 h: $19.90)

Accession: 055260532

Download citation: RISBibTeXText

PMID: 23477362

DOI: 10.3109/0284186X.2013.765966


Related references

(P124) dosimetric comparison of three-dimensional conformal proton radiotherapy and intensity-modulated proton therapy for treatment of pediatric hodgkin lymphoma. Oncology 29(4 Suppl 1): -, 2015

Proton Therapy for Pediatric Hodgkin Lymphoma. Pediatric Blood & Cancer 63(9): 1522-1526, 2016

Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?. Strahlentherapie und Onkologie 189(1): 54-61, 2013

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110(1): 179-185, 2007

Proton beam therapy for the management of mediastinal Hodgkin lymphoma in a young female patient. Cancer Radiotherapie, 2018

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. International Journal of Radiation Oncology, Biology, Physics 83(1): 260-267, 2012

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Journal of Clinical Oncology 23(30): 7555-7564, 2005

Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients. International Journal of Radiation Oncology, Biology, Physics 81(4): E667-E671, 2012

How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?. Clinical Lymphoma, Myeloma & Leukemia 17(11): 710-715, 2017

Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold. RadioTherapy and Oncology 125(1): 41-47, 2017

Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric Blood & Cancer 63(10): 1794-1799, 2016

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Annals of Oncology 24(12): 3065-3069, 2014

Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncologica 55(11): 1378-1380, 2016

Successful treatment of non-Hodgkin's lymphoma with rituximab and dose-adjusted CHOP therapy in a patient with concomitant end-stage renal disease requiring haemodialysis. Ndt Plus 4(3): 186-189, 2011

Therapy of high malignant non hodgkin lymphoma stage i of low malignant non hodgkin lymphoma stages i and ii and centroblastic centrocytic lymphoma stages i iii. Journal of Cancer Research & Clinical Oncology 111(SUPPL): S5, 1986